Readouts for two late-stage, potentially registrational trials of nemvaleukin alfa expected in late Q1/early Q2 2025 for platinum-resistant ...

Medically reviewed by Jennifer Steinhoff, MD The groin is located where the upper part of the thighs meets the lowest parts ...

Oxford, UK and San Jose, California, 9 January 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of ...

Zentalis Pharmaceuticals has won a U.S. Food and Drug Administration fast-track designation for its lead product candidate azenosertib for certain cancer patients with high levels of the Cyclin E1 ...

Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, ...